Here’s an overview of some of last week’s most interesting news, articles, interviews and videos: Malware spread through ...
Transformer on MSNOpinion

Policy can still work on short timelines

Transformer Weekly: California makes a bid to regulate AI, a new FRONTIER ACT, and Anthropic’s record-breaking IPO ...
The AI-driven biotech has secured FDA alignment on a pivotal trial for its FAP therapy, with a study start planned for 2027.
If you checked your bank balance, booked a flight or ordered groceries online today, there is a good chance your request was ...
Spread the loveAlright, let’s talk about Java. Specifically, let’s talk about Java and the kind of headaches it can cause ...
REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no ...
Recursion Pharmaceuticals, Inc. ( RXRX) announced Wednesday that it has reached alignment with the U.S. Food and Drug Administration (FDA) on the design of its registrational Phase 3 trial of REC-4881 ...
Recursion Pharmaceuticals said on November 18, 2026 that it had aligned with the U.S. Food and Drug Administration on a ...
Recursion announces FDA alignment for REC-4881’s Phase 3 trial in familial adenomatous polyposis, targeting crucial adenoma excision outcomes.
REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no approved pharmacologic therapies. Its potential as a first-in-class oral therapy ...
In the field of artificial intelligence, machine learning is a branch that uses data and algorithms to imitate human learning. It's an ongoing process in which computers can improve their accuracy ...
Java4Shell (CVE-2026-114938) is a critical OpenJDK Base64 decoder bug that can lead to RCE. See who’s affected, how to check ...